Professor Tarek Zawawy talks about CardioAlex on international terms saying, “ CardioAlex is famous for its international standard. It’s not engaged with local or regional topics. Moreover, its international participation in many events makes CardioAlex up to date with the latest news and techniques. In addition, the participated guest speakers and societies have their input every year on the scientific level”
Adding the following: CardioAlex is known by its international standard. It’s not engaged with local or regional topics from only Egypt. Its international participation in many events makes CardioAlex up to date with the latest news and techniques. Also, the participated guest speakers and societies have their input every year on the scientific level.
What’s new in CardioAlex 2017
CardioAlex has changed and grown from being a regional meeting to be an interventional one with wide range of topics
Cardio-Alex,2017 is the main conference of CVRP foundation, concerned with recent researches in the cardiovascular diseases and co-morbidites related to cardiac diseases
CardioAlex is an international cardiology meeting including different levels of scientific educational materials and live cases
A wish… (CardioAlex & Egypt)
CardioAlex adds for the medical development in Egypt and has a positive effect on the region,s physicians
I hope that the contribution of cardiologists allover the world will build a valuable and attractive scientific programme
What’s your best advice for people with heart disease? Healthy diet & exercise?
Life-Style Modification: Is it Important?
Moderate physical activity 30-45 min, 3-5 days/week, with eventual goal of ≥30 min on most (and preferably all) days of the week
- Improves CV fitness, weight control, sensitivity to insulin, reduces incidence of diabetes
- Weight loss
- Improves lipids, insulin sensitivity, BP levels, reduces incidence of diabetes
- DIETARY MODIFICATIONS
- Adequate fluid consumption- 1.5 liters / day
- Limit salt intake up to 6 g/day
- Calories based on individual needs, initiate plan to achieve reasonable weight (BMI between 18 and 24 kg/m2)
- Select 5 to 6 servings/day of fruits and vegetables and 6 servings/day of whole-grain products.
- Choose foods with lower glycemic index.
- Use olive oil instead of sunflower oil/coconut oil/palm oil in preparation of food.
- Low fat diary products- yogurt & cheese every day, reduce butter and cream.
- Vegetables and fruits every day.
- Fish: Herring, Mackerel, Salmon, Sardine and Tuna- A high intake of omega-3 fatty acids is associated with a lower risk of coronary heart disease.
- Meat: Poultry recommended over beef, pork and lamb due to lower content of fat and saturated fatty acids.
Red meat only 2-3 times a month.
- Eggs : 2-3 eggs a week (“hidden” eggs in baked or cooked food (e.g. cake, biscuits).
Smoking Cessation / Avoidance:
- Smoking is a risk factor for development in children and adults
- Both passive and active exposure harmful
- A major risk factor for:
- insulin resistance and metabolic syndrome
- macrovascular disease (PVD, MI, Stroke)
- microvascular complications of diabetes
- pulmonary disease.
Benefit of smoking cessation
Several large observational studies, all of which had at least 5 years of follow-up and a meta-analysis including these studies, showed a substantial reduction in mortality [RR: 0.64 (I: 0.58-0.71)] in patients with a history of MI, CABG, angioplasty, or known CHD, who quit smoking compared with patients who continued to smoke.
The overall mortality risk of smokers who quit decreases by 50% in the first couple of years and tends to approach that of nonsmokers in approximately 5-15 years of cessation of smoking
Screening for dyslipidemias should be considered in all adult men ≥40 years of age and in women ≥50 years of age or postmenopausal, particularly in the presence of other risk factors
dyslipidemia may contribute to an increased risk of developing CVD
Elevated serum cholesterol is associated with increased risk of CHD, Re-infarction and CVD mortality (all cause , CHD, Stroke)
For every 30-mg/dL change in LDL-C, the relative risk for CHD is changed in proportion by about 30%.
Every 10% reduction in total cholesterol results in:
15% decrease of CHD mortality
11% decrease total mortality
The targeted approach to lipid management is primarily aimed at reducing LDL-C. For patients at a very high total CV risk, the goal is an LDL-C ,1.8 mmol/L (70 mg/dL). At least a 50% reduction from baseline (if .1.8 mmol/L) should also be achieved.
For subjects at high total CV risk, the goal is an LDL-C level ,2.6 mmol/L (100 mg/dL). At least a 50% reduction from baseline [if .2.6 mmol/L (100 mg/dL)] should also be achieved. In people at moderate total CV risk, the LDL-C goal is ,3 mmol/L (115 mg/dL)
When secondary targets are used the recommendations are
– non-HDL-C ,2.6 mmol/L (100 mg/dL) and ,3.4 mmol/L (130 mg/dL) in subjects at very high and high total CV risk, respectively (Class IIa, Level B).
– apoB ,80 mg/dL and ,100 mg/dL in those at very high and high total CV risk, respectively (Class IIa, Level B)